HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:HCA
- CUSIP: 40412C10
- Web: www.hcahealthcare.com
Capitalization:- Market Cap: $27.56 billion
- Outstanding Shares: 361,249,000
Average Prices:- 50 Day Moving Avg: $78.55
- 200 Day Moving Avg: $83.38
- 52 Week Range: $67.00 - $91.03
P/E:- Trailing P/E Ratio: 10.41
- Foreward P/E Ratio: 9.73
- P/E Growth: 1.06
Sales & Book Value:- Annual Revenue: $42.27 billion
- Price / Sales: 0.65
- Book Value: ($18.72) per share
- Price / Book: -4.08
Profitability:- EBIDTA: $8.2 billion
- Net Margins: 6.64%
- Return on Equity: -48.08%
- Return on Assets: 7.90%
Debt:- Debt-to-Equity Ratio: -6.19%
- Current Ratio: 1.62%
- Quick Ratio: 1.35%
Misc:- Average Volume: 2.01 million shs.
- Beta: 0.67
- Short Ratio: 7.27
Frequently Asked Questions for HCA Holdings (NYSE:HCA)
What is HCA Holdings' stock symbol?
HCA Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."
How were HCA Holdings' earnings last quarter?
HCA Holdings, Inc. (NYSE:HCA) released its quarterly earnings data on Tuesday, July, 25th. The company reported $1.75 EPS for the quarter, missing analysts' consensus estimates of $1.80 by $0.05. The firm earned $10.73 billion during the quarter, compared to the consensus estimate of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. HCA Holdings's revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.66 earnings per share. View HCA Holdings' Earnings History.
What guidance has HCA Holdings issued on next quarter's earnings?
HCA Holdings updated its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $7.00-7.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.35. The company issued revenue guidance of $43.0-44.0 billion, compared to the consensus revenue estimate of $43.37 billion.
Where is HCA Holdings' stock going? Where will HCA Holdings' stock price be in 2017?
16 brokers have issued 12-month price targets for HCA Holdings' shares. Their forecasts range from $81.00 to $103.00. On average, they anticipate HCA Holdings' share price to reach $92.60 in the next year. View Analyst Ratings for HCA Holdings.
What are analysts saying about HCA Holdings stock?
Here are some recent quotes from research analysts about HCA Holdings stock:
- 1. According to Zacks Investment Research, "HCA Healthcare’s shares have outperformed the industry year to date. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. During the second quarter results the company reported earnings of $1.77 per share which lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance." (8/8/2017)
- 2. Cantor Fitzgerald analysts commented, "CMS proposed a better than expected FY 18 hospital inpatient (IPPS) rate increase of 1.6% for operating payments and a total increase of 2.9%, including a new reimbursement methodology for uncompensated care. Although the impact of the new rates will vary among hospitals depending on patient mix and the level of uncompensated care, we expect better rates will help hospital stocks, which have been hurt by concern for the ACA. The proposed hospital IPPS rates were significantly higher than our 1% estimate (vs. 0.8%-2.3% over past five years)." (4/17/2017)
Who are some of HCA Holdings' key competitors?
Some companies that are related to HCA Holdings include Fresenius Medical Care Corporation (FMS), Laboratory Corporation of America Holdings (LH), Quest Diagnostics Incorporated (DGX), DaVita HealthCare Partners (DVA), Universal Health Services (UHS), NMC Health PLC (NMC), HealthSouth Corporation (HLS), Acadia Healthcare Company (ACHC), Mednax (MD), Molina Healthcare (MOH), Chemed Corp. (CHE), Select Medical Holdings (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO) and Community Health Systems (CYH).
Who are HCA Holdings' key executives?
HCA Holdings' management team includes the folowing people:
- R. Milton Johnson, Chairman of the Board, Chief Executive Officer
- Samuel N. Hazen, President, Chief Operating Officer
- William B. Rutherford, Chief Financial Officer, Executive Vice President
- Michael S. Cuffe M.D., President — Physician Services Group
- Jon Mark Foster, President - American Group
- Charles J. Hall, President - National Group
- Arnold Bruce Moore Jr., President - Service Line and Operations Integration
- Jonathan B. Perlin M.D., President - Clinical Services Group, Chief Medical Officer
- J. William B. Morrow, Senior Vice President - Finance, Treasurer
- Paul Martin Paslick, Senior Vice President, Chief Information Officer
Who owns HCA Holdings stock?
HCA Holdings' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (5.37%), Glenview Capital Management LLC (4.12%), State Street Corp (3.48%), Harris Associates L P (3.29%), Magellan Asset Management Ltd (2.68%) and Longview Partners Guernsey LTD (2.48%). Company insiders that own HCA Holdings stock include A Bruce Moore Jr, Alan R Yuspeh, Charles J Hall, Charles O Holliday Jr, Christopher F Wyatt, David Gwin Anderson, Henry R Kravis, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph N Steakley, Juan Vallarino, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Holdings.
Who sold HCA Holdings stock? Who is selling HCA Holdings stock?
HCA Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, UBS Asset Management Americas Inc., State Street Corp, AXA, Russell Investments Group Ltd., BB&T Securities LLC, Harris Associates L P and Canada Pension Plan Investment Board. Company insiders that have sold HCA Holdings stock in the last year include A Bruce Moore Jr, Charles J Hall, Christopher F Wyatt, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman and Sandra L Morgan. View Insider Buying and Selling for HCA Holdings.
Who bought HCA Holdings stock? Who is buying HCA Holdings stock?
HCA Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Harbour Capital Advisors LLC, Northwestern Mutual Investment Management Company LLC, Parametric Portfolio Associates LLC, Arrowstreet Capital Limited Partnership, Victory Capital Management Inc., Longview Partners Guernsey LTD, Glenview Capital Management LLC and PGGM Investments. Company insiders that have bought HCA Holdings stock in the last two years include Charles O Holliday Jr and Thomas F Frist Jr. View Insider Buying and Selling for HCA Holdings.
How do I buy HCA Holdings stock?
Shares of HCA Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCA Holdings' stock price today?
One share of HCA Holdings stock can currently be purchased for approximately $76.30.
MarketBeat Community Rating for HCA Holdings (NYSE HCA)MarketBeat's community ratings are surveys of what our community members think about HCA Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for HCA Holdings (NYSE:HCA) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 12 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.75) |
| Consensus Price Target: | $92.60 (21.36% upside) |
Analysts' Ratings History for HCA Holdings (NYSE:HCA)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/7/2017 | KeyCorp | Reiterated Rating | Buy | $95.00 | Low |  |
| 9/6/2017 | Cantor Fitzgerald | Reiterated Rating | Buy | $95.00 | Low | |
| 8/22/2017 | Robert W. Baird | Lower Price Target | Outperform | $95.00 -> $93.00 | Low | |
| 8/17/2017 | Morgan Stanley | Lower Price Target | Equal Weight | $88.00 -> $85.00 | Low | |
| 8/14/2017 | Argus | Lower Price Target | Buy | $100.00 -> $93.00 | Low | |
| 7/26/2017 | Citigroup Inc. | Lower Price Target | Neutral | $89.00 -> $87.00 | Medium | |
| 7/26/2017 | Bank of America Corporation | Downgrade | Buy -> Neutral | $102.00 -> $92.00 | Medium | |
| 6/6/2017 | Leerink Swann | Upgrade | Market Perform -> Outperform | $92.00 -> $100.00 | Low | |
| 4/4/2017 | Deutsche Bank AG | Initiated Coverage | Buy | $103.00 | Low | |
| 3/27/2017 | Mizuho | Upgrade | Neutral -> Buy | $98.00 | High | |
| 2/1/2017 | Royal Bank of Canada | Reiterated Rating | Outperform | $95.00 -> $98.00 | N/A | |
| 1/31/2017 | Evercore ISI | Boost Price Target | Buy | $88.00 | N/A | |
| 1/17/2017 | Avondale Partners | Upgrade | Market Perform -> Outperform | $96.00 | N/A | |
| 1/4/2017 | Piper Jaffray Companies | Initiated Coverage | Overweight | $81.00 | N/A | |
| 11/15/2016 | Sanford C. Bernstein | Reiterated Rating | Market Perform | $89.00 -> $85.00 | N/A | |
| 10/25/2016 | Wolfe Research | Initiated Coverage | Outperform | | N/A | |
| 9/6/2016 | Jefferies Group LLC | Reiterated Rating | Buy | | N/A | |
| 7/29/2016 | Credit Suisse Group | Reiterated Rating | Buy | $87.00 | N/A | |
| 7/29/2016 | J P Morgan Chase & Co | Downgrade | Overweight -> Neutral | $85.00 | N/A | |
| 6/1/2016 | Longbow Research | Downgrade | Outperform -> Market Perform | $74.00 | N/A | |
| 6/1/2016 | Barclays PLC | Lower Price Target | Overweight | $80.00 -> $79.00 | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Buy | | N/A | |
| 5/4/2016 | Oppenheimer Holdings, Inc. | Reiterated Rating | Buy | | N/A | |
| 5/4/2016 | Wedbush | Reiterated Rating | Outperform | $88.00 -> $90.00 | N/A | |
| 1/6/2016 | Raymond James Financial, Inc. | Upgrade | Market Perform -> Outperform | $95.00 | N/A | |
| 1/4/2016 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | N/A | |
| 12/17/2015 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $80.00 | N/A | |
| 10/19/2015 | Susquehanna Bancshares Inc | Lower Price Target | Positive | $108.00 -> $88.00 | N/A | |
(Data available from 9/19/2015 forward)
Earnings History for HCA Holdings (NYSE:HCA)Earnings History by Quarter for HCA Holdings (NYSE HCA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/25/2017 | Q2 2017 | $1.80 | $1.75 | $10.76 billion | $10.73 billion | View | N/A | |
| 5/2/2017 | Q1 2017 | $1.74 | $1.74 | $10.64 billion | $10.62 billion | View | Listen | |
| 1/31/2017 | Q416 | $1.78 | $1.89 | $10.67 billion | $10.64 billion | View | N/A | |
| 10/27/2016 | Q316 | $1.42 | $1.61 | $10.41 billion | $10.27 billion | View | Listen | |
| 7/28/2016 | Q216 | $1.56 | $1.66 | $10.49 billion | $10.32 billion | View | Listen | |
| 5/3/2016 | Q116 | $1.49 | $1.71 | $10.24 billion | $10.26 billion | View | N/A | |
| 1/28/2016 | Q415 | $1.40 | $1.69 | $10.16 billion | $10.25 billion | View | Listen | |
| 10/27/2015 | Q315 | $1.19 | $1.17 | $9.90 billion | $9.86 billion | View | Listen | |
| 8/5/2015 | Q215 | $1.34 | $1.37 | $9.82 billion | $9.90 billion | View | N/A | |
| 5/5/2015 | Q115 | $1.34 | $1.35 | $9.56 billion | $9.68 billion | View | N/A | |
| 2/3/2015 | Q414 | $1.25 | $1.33 | $9.59 billion | $9.64 billion | View | N/A | |
| 10/28/2014 | Q314 | $1.05 | $1.16 | $9.12 billion | $9.22 billion | View | N/A | |
| 7/29/2014 | Q214 | $1.37 | $1.37 | $8.98 billion | $9.96 billion | View | N/A | |
| 4/29/2014 | Q114 | $0.85 | $0.84 | $8.90 billion | $9.68 billion | View | N/A | |
| 2/4/2014 | Q114 | $0.86 | $0.92 | $8.82 billion | $8.43 billion | View | N/A | |
| 11/5/2013 | Q313 | $0.74 | $0.79 | $8.40 billion | $9.41 billion | View | N/A | |
| 8/1/2013 | Q2 2013 | $0.83 | $0.91 | $8.44 billion | $8.45 billion | View | Listen | |
| 5/2/2013 | Q1 2013 | $0.82 | $0.79 | $9.38 billion | $8.44 billion | View | N/A | |
| 2/5/2013 | Q4 2012 | $0.83 | $0.92 | $8.95 billion | $8.43 billion | View | N/A | |
| 11/1/2012 | Q312 | $0.90 | $0.78 | $8.04 billion | $8.06 billion | View | N/A | |
| 8/6/2012 | | $0.78 | $0.85 | | | View | N/A | |
| 5/3/2012 | | $0.99 | $1.18 | | | View | N/A | |
| 2/6/2012 | | $0.76 | $0.94 | | | View | N/A | |
| 11/1/2011 | | $0.43 | $0.60 | | | View | N/A | |
| 7/25/2011 | | $0.59 | $0.55 | | | View | N/A | |
| 5/4/2011 | | $0.75 | $0.85 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for HCA Holdings (NYSE:HCA)2017 EPS Consensus Estimate: $7.26
2018 EPS Consensus Estimate: $7.98
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 6 | $1.66 | $1.82 | $1.77 |
| Q2 2017 | 6 | $1.78 | $1.86 | $1.82 |
| Q3 2017 | 6 | $1.57 | $1.69 | $1.64 |
| Q4 2017 | 6 | $1.97 | $2.09 | $2.04 |
| Q1 2018 | 2 | $1.81 | $1.90 | $1.86 |
| Q2 2018 | 2 | $1.95 | $2.05 | $2.00 |
| Q3 2018 | 2 | $1.81 | $1.92 | $1.87 |
| Q4 2018 | 2 | $2.23 | $2.28 | $2.26 |
| Q1 2019 | 1 | $2.05 | $2.05 | $2.05 |
| Q2 2019 | 1 | $2.19 | $2.19 | $2.19 |
(Data provided by Zacks Investment Research)
Current Dividend Information for HCA Holdings (NYSE:HCA)| Most Recent Dividend: | 12/21/2012 |
| Dividend Yield: | 0.00% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
|
Dividend History by Quarter for HCA Holdings (NYSE HCA)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 12/6/2012 | special | $2.00 | | 12/13/2012 | 12/17/2012 | 12/21/2012 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for HCA Holdings (NYSE:HCA)Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 73.75%
Insider Trades by Quarter for HCA Holdings (NYSE:HCA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/15/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $79.88 | $171,742.00 | |
| 7/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $86.44 | $185,846.00 | |
| 6/22/2017 | Jonathan B. Perlin | Insider | Sell | 71,063 | $86.00 | $6,111,418.00 | |
| 6/15/2017 | Michael S. Cuffe | Insider | Sell | 2,150 | $84.86 | $182,449.00 | |
| 5/23/2017 | Jana Joustra Davis | SVP | Sell | 54,689 | $82.35 | $4,503,639.15 | |
| 5/17/2017 | Sandra L Morgan | SVP | Sell | 5,915 | $82.74 | $489,407.10 | |
| 5/15/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $84.52 | $181,718.00 | |
| 5/11/2017 | Jana Joustra Davis | SVP | Sell | 8,302 | $85.02 | $705,836.04 | |
| 5/10/2017 | Jane D Englebright | SVP | Sell | 5,005 | $85.31 | $426,976.55 | |
| 5/5/2017 | Robert A Waterman | SVP | Sell | 246,000 | $83.12 | $20,447,520.00 | |
| 5/5/2017 | Thomas F Frist Jr | Major Shareholder | Buy | 361,205 | $83.06 | $30,001,687.30 | |
| 4/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $85.00 | $182,750.00 | |
| 3/27/2017 | Ravi S Chari | SVP | Sell | 31,956 | $90.00 | $2,876,040.00 | |
| 2/7/2017 | John M Steele | SVP | Sell | 31,535 | $82.55 | $2,603,214.25 | |
| 2/3/2017 | Charles J Hall | Insider | Sell | 100,000 | $83.79 | $8,379,000.00 | |
| 2/3/2017 | Jana Joustra Davis | SVP | Sell | 7,903 | $82.49 | $651,918.47 | |
| 2/2/2017 | Charles J Hall | Insider | Sell | 100,000 | $82.38 | $8,238,000.00 | |
| 1/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $80.00 | $172,000.00 | |
| 1/9/2017 | Michael S. Cuffe | Insider | Sell | 4,300 | $78.00 | $335,400.00 | |
| 11/9/2016 | A Bruce Moore Jr | Insider | Sell | 167,967 | $73.65 | $12,370,769.55 | |
| 11/8/2016 | Sandra L Morgan | SVP | Sell | 18,556 | $76.84 | $1,425,843.04 | |
| 11/7/2016 | Christopher F Wyatt | SVP | Sell | 3,152 | $79.00 | $249,008.00 | |
| 10/28/2016 | Michael S. Cuffe | Insider | Sell | 2,150 | $79.41 | $170,731.50 | |
| 10/28/2016 | P. Martin Paslick | SVP | Sell | 36,004 | $78.79 | $2,836,755.16 | |
| 5/24/2016 | Alan R Yuspeh | SVP | Sell | 15,000 | $77.82 | $1,167,300.00 | |
| 5/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $76.20 | $196,215.00 | |
| 5/20/2016 | Joseph N Steakley | SVP | Sell | 16,327 | $77.07 | $1,258,321.89 | |
| 5/10/2016 | Henry R Kravis | Major Shareholder | Sell | 9,360,958 | $80.12 | $749,999,954.96 | |
| 5/9/2016 | Juan Vallarino | SVP | Sell | 13,501 | $81.27 | $1,097,226.27 | |
| 5/6/2016 | Charles J Hall | Insider | Sell | 100,023 | $80.99 | $8,100,862.77 | |
| 5/6/2016 | Joseph N Steakley | SVP | Sell | 60,004 | $80.82 | $4,849,523.28 | |
| 5/5/2016 | Jana Joustra Davis | SVP | Sell | 11,970 | $80.02 | $957,839.40 | |
| 5/4/2016 | Charles O Holliday Jr | Director | Buy | 4,000 | $79.68 | $318,720.00 | |
| 5/4/2016 | P. Martin Paslick | SVP | Sell | 18,000 | $79.46 | $1,430,280.00 | |
| 4/28/2016 | John M Steele | SVP | Sell | 40,004 | $82.56 | $3,302,730.24 | |
| 4/28/2016 | Jonathan B Perlin | CMO | Sell | 30,000 | $82.00 | $2,460,000.00 | |
| 4/25/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $80.73 | $207,879.75 | |
| 4/18/2016 | John M Steele | SVP | Sell | 19,464 | $81.00 | $1,576,584.00 | |
| 4/14/2016 | John M Steele | SVP | Sell | 3,036 | $81.00 | $245,916.00 | |
| 3/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $76.19 | $196,189.25 | |
| 3/23/2016 | John M Steele | SVP | Sell | 22,500 | $78.00 | $1,755,000.00 | |
| 2/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $70.00 | $180,250.00 | |
| 2/19/2016 | Jana Joustra Davis | SVP | Sell | 36,159 | $67.17 | $2,428,800.03 | |
| 2/17/2016 | Jane D. Englebright | SVP | Sell | 4,436 | $67.08 | $297,566.88 | |
| 2/1/2016 | David Gwin Anderson | SVP | Sell | 35,013 | $70.52 | $2,469,116.76 | |
| 1/29/2016 | Victor L. Campbell | SVP | Sell | 165,016 | $68.86 | $11,363,001.76 | |
| 1/28/2016 | Michael S. Cuffe | insider | Sell | 5,150 | $70.00 | $360,500.00 | |
| 12/1/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $70.00 | $180,250.00 | |
| 10/26/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $70.00 | $180,250.00 | |
| 9/24/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $83.42 | $214,806.50 | |
| 8/25/2015 | Juan Vallarino | SVP | Sell | 27,002 | $85.76 | $2,315,691.52 | |
| 8/24/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $82.32 | $211,974.00 | |
| 8/17/2015 | Donald W Stinnett | SVP | Sell | 67,506 | $91.25 | $6,159,922.50 | |
| 8/14/2015 | Alan R Yuspeh | SVP | Sell | 14,000 | $91.24 | $1,277,360.00 | |
| 8/13/2015 | Juan Vallarino | SVP | Sell | 11,036 | $90.89 | $1,003,062.04 | |
| 6/25/2015 | Jonathan B Perlin | CMO | Sell | 32,010 | $87.31 | $2,794,793.10 | |
| 6/11/2015 | R Milton Johnson | CEO | Sell | 140,642 | $83.89 | $11,798,457.38 | |
| 5/22/2015 | Donald W Stinnett | SVP | Sell | 22,502 | $82.39 | $1,853,939.78 | |
| 5/20/2015 | Jana Joustra Davis | SVP | Sell | 3,302 | $82.74 | $273,207.48 | |
| 5/19/2015 | Jon M Foster | Insider | Sell | 36,000 | $81.00 | $2,916,000.00 | |
| 5/19/2015 | Jonathan B Perlin | CMO | Sell | 18,000 | $83.00 | $1,494,000.00 | |
| 5/18/2015 | A Bruce Moore Jr | Insider | Sell | 100,000 | $80.83 | $8,083,000.00 | |
| 5/18/2015 | David Gwin Anderson | SVP | Sell | 30,000 | $80.67 | $2,420,100.00 | |
| 5/18/2015 | Jonathan B Perlin | CMO | Sell | 18,000 | $81.00 | $1,458,000.00 | |
| 5/18/2015 | R Milton Johnson | CEO | Sell | 140,642 | $79.89 | $11,235,889.38 | |
| 5/7/2015 | Charles J Hall | Insider | Sell | 252,026 | $74.54 | $18,786,018.04 | |
| 4/15/2015 | Samuel N Hazen | COO | Sell | 180,000 | $80.00 | $14,400,000.00 | |
| 2/23/2015 | Charles J Hall | Insider | Sell | 50,000 | $70.10 | $3,505,000.00 | |
| 2/12/2015 | Jane D Englebright | SVP | Sell | 10,774 | $69.06 | $744,052.44 | |
| 1/12/2015 | Donald W Stinnett | SVP | Sell | 2,521 | $76.00 | $191,596.00 | |
| 12/23/2014 | John M Steele | SVP | Sell | 14,000 | $75.00 | $1,050,000.00 | |
| 12/23/2014 | Jonathan B Perlin | CMO | Sell | 10,000 | $75.00 | $750,000.00 | |
| 12/23/2014 | Samuel N Hazen | Insider | Sell | 180,051 | $75.00 | $13,503,825.00 | |
| 11/3/2014 | John M Steele | SVP | Sell | 13,000 | $72.00 | $936,000.00 | |
| 11/3/2014 | Jonathan B Perlin | CMO | Sell | 10,000 | $72.00 | $720,000.00 | |
| 8/4/2014 | Samuel N Hazen | Insider | Sell | 19,374 | $66.00 | $1,278,684.00 | |
| 7/30/2014 | David Gwin Anderson | SVP | Sell | 22,524 | $66.53 | $1,498,521.72 | |
| 7/16/2014 | Juan Vallarino | SVP | Sell | 15,000 | $60.00 | $900,000.00 | |
| 6/20/2014 | Juan Vallarino | SVP | Sell | 15,000 | $57.50 | $862,500.00 | |
| 6/5/2014 | Jonathan B Perlin | CMO | Sell | 20,000 | $55.00 | $1,100,000.00 | |
| 5/6/2014 | Wayne Joseph Riley | Director | Sell | 10,000 | $52.00 | $520,000.00 | |
| 5/5/2014 | David Gwin Anderson | SVP | Sell | 42,007 | $52.22 | $2,193,605.54 | |
| 5/2/2014 | A Bruce Moore, Jr. | Insider | Sell | 75,174 | $52.53 | $3,948,890.22 | |
| 5/1/2014 | Juan Vallarino | SVP | Sell | 15,000 | $52.50 | $787,500.00 | |
| 4/30/2014 | John Rowe | Director | Buy | 14,356 | $52.24 | $749,957.44 | |
| 2/19/2014 | Charles Hall | Insider | Sell | 185,596 | $49.92 | $9,264,952.32 | |
| 2/7/2014 | Samuel Hazen | Insider | Sell | 29,016 | $48.00 | $1,392,768.00 | |
| 11/26/2013 | Juan Vallarino | SVP | Sell | 22,042 | $45.00 | $991,890.00 | |
| 9/18/2013 | Donald Stinnett | SVP | Sell | 12,500 | $42.00 | $525,000.00 | |
| 8/20/2013 | John Steele | SVP | Sell | 33,189 | $38.63 | $1,282,091.07 | |
| 8/14/2013 | Juan Vallarino | SVP | Sell | 50,142 | $39.49 | $1,980,107.58 | |
| 5/17/2013 | Jon M Foster | Insider | Sell | 15,955 | $39.04 | $622,883.20 | |
| 8/8/2012 | Of America Corp /De/ Bank | Major Shareholder | Sell | 145,491 | $26.91 | $3,915,162.81 | |
(Data available from 1/1/2013 forward)
Headline Trends for HCA Holdings (NYSE:HCA)
Latest Headlines for HCA Holdings (NYSE:HCA)
| Source: |
|
| Date | Headline |
|---|
 | Equities Analysts Issue Forecasts for HCA Holdings, Inc.'s Q1 2019 Earnings (HCA)
www.americanbankingnews.com - September 18 at 7:52 AM |
 | HCA Healthcare Rides on Acquisitions, Weak Volumes Bother - Nasdaq
www.nasdaq.com - September 12 at 9:07 PM |
| Zacks: Brokerages Expect HCA Holdings, Inc. (HCA) Will Announce Quarterly Sales of $10.71 Billion
www.americanbankingnews.com - September 11 at 9:22 AM |
| HCA Holdings, Inc. (HCA) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 9 at 11:26 AM |
| Analysts Expect HCA Holdings, Inc. (HCA) Will Post Earnings of $1.63 Per Share
www.americanbankingnews.com - September 9 at 10:22 AM |
 | HCA Healthcare (HCA) Presents At Baird's 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - September 8 at 7:53 PM |
| HCA Holdings, Inc. (HCA) Given "Buy" Rating at KeyCorp
www.americanbankingnews.com - September 8 at 6:11 PM |
| HCA Holdings, Inc. (HCA) Cut to Hold at ValuEngine
www.americanbankingnews.com - September 7 at 11:58 PM |
| HCA Holdings' (HCA) Buy Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - September 7 at 3:26 PM |
| The Ensign Group (ENSG) Buys 2 Nursing Facilities in Arizona - Nasdaq
www.nasdaq.com - September 6 at 7:19 PM |
 | Unpaid Medical Bills Rise As Congress Weighs Obamacare Fix
finance.yahoo.com - September 4 at 4:02 PM |
| Head-To-Head Review: HCA Holdings (HCA) & Community Health Systems (CYH)
www.americanbankingnews.com - September 3 at 2:30 PM |
| HCA Holdings (HCA) vs. China Cord Blood Corporation (CO) Head to Head Contrast
www.americanbankingnews.com - September 2 at 4:22 AM |
| Community Health System Divests Hospitals to Lower Debts - Nasdaq
www.nasdaq.com - September 1 at 7:45 PM |
| Ashley Johnson Appointed Chief Financial Officer of HCA Healthcare’s American Group
finance.yahoo.com - September 1 at 7:45 PM |
 | HCA to Present at September Healthcare Conference - Business Wire (press release)
www.businesswire.com - September 1 at 12:26 AM |
| HCA to Present at September Healthcare Conference
finance.yahoo.com - August 31 at 7:20 PM |
| Tenet Healthcare CEO Trevor Fetter To Leave Hospital Chain
finance.yahoo.com - August 31 at 7:20 PM |
| HCA Healthcare Gives up to $2 Million for Hurricane Relief in Texas
finance.yahoo.com - August 29 at 7:55 PM |
| Harvey likely to have modest impact on HCA results: Mizuho
finance.yahoo.com - August 29 at 7:55 PM |
| Why Is HCA Holdings (HCA) Down 3.3% Since the Last Earnings Report?
finance.yahoo.com - August 28 at 7:00 PM |
| Zacks: Analysts Anticipate HCA Holdings, Inc. (HCA) Will Post Quarterly Sales of $10.71 Billion
www.americanbankingnews.com - August 23 at 1:44 AM |
| Financial Survey: Tenet Healthcare Corporation (THC) vs. HCA Holdings (HCA)
www.americanbankingnews.com - August 22 at 10:24 PM |
| Robert W. Baird Lowers HCA Holdings, Inc. (HCA) Price Target to $93.00
www.americanbankingnews.com - August 22 at 11:58 AM |
| HMS Holdings Corp (HMSY) & HCA Holdings (HCA) Head-To-Head Analysis
www.americanbankingnews.com - August 22 at 12:18 AM |
| HCA Holdings, Inc. 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - August 18 at 7:13 PM |
| HCA Holdings, Inc. (HCA) Insider Sells $171,742.00 in Stock
www.americanbankingnews.com - August 17 at 7:58 PM |
| Morgan Stanley Lowers HCA Holdings, Inc. (HCA) Price Target to $85.00
www.americanbankingnews.com - August 17 at 5:32 PM |
| Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q2 2017 Update
seekingalpha.com - August 17 at 12:23 AM |
| HCA Holdings, Inc. (HCA) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - August 15 at 3:10 PM |
| HCA Holdings, Inc. (NYSE:HCA) Given New $93.00 Price Target at Argus
www.americanbankingnews.com - August 14 at 11:40 AM |
| Axa Buys Micron Technology Inc, UBS Group AG, Air Products & Chemicals Inc, Sells HCA ...
www.nasdaq.com - August 12 at 12:51 AM |
| HCA Holdings, Inc. (NYSE:HCA) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 8 at 2:36 PM |
 | HCA's TriStar continues push for Brentwood emergency department ... - Nashville Business Journal
www.bizjournals.com - August 8 at 1:21 AM |
| Tenet Healthcare cuts forecast on weak patient admissions - Nasdaq
www.nasdaq.com - August 8 at 1:21 AM |
 | UPDATE 2-Tenet Healthcare cuts forecast on weak patient admissions
www.cnbc.com - August 7 at 8:21 PM |
 | See How HCA Healthcare Ranks Among Analysts' Top Picks With Strong Buyback Activity
www.thestreet.com - August 7 at 8:21 PM |
| HCA Healthcare, Inc. – Value Analysis (NYSE:HCA) : August 7, 2017
finance.yahoo.com - August 7 at 8:21 PM |
| HCA Holdings, Inc. (NYSE:HCA) Downgraded by BidaskClub
www.americanbankingnews.com - August 5 at 2:24 PM |
| $10.71 Billion in Sales Expected for HCA Holdings, Inc. (NYSE:HCA) This Quarter
www.americanbankingnews.com - August 5 at 7:09 AM |
| HCA Holdings, Inc. (HCA) Expected to Post Earnings of $1.63 Per Share
www.americanbankingnews.com - August 3 at 4:14 PM |
| Q3 2017 Earnings Estimate for HCA Holdings, Inc. Issued By Jefferies Group (HCA)
www.americanbankingnews.com - August 3 at 8:28 AM |
| HCA Holdings, Inc. Expected to Post FY2017 Earnings of $7.15 Per Share (NYSE:HCA)
www.americanbankingnews.com - August 2 at 10:38 AM |
| Jefferies Group Equities Analysts Decrease Earnings Estimates for HCA Holdings, Inc. (HCA)
www.americanbankingnews.com - August 2 at 10:38 AM |
| D.C.-area hospital gears up for $72M expansion
www.bizjournals.com - August 1 at 8:02 PM |
| HCA Holdings, Inc. (HCA) Forecasted to Earn Q3 2017 Earnings of $1.66 Per Share
www.americanbankingnews.com - July 28 at 11:44 AM |
| Q3 2017 EPS Estimates for HCA Holdings, Inc. (NYSE:HCA) Lowered by Leerink Swann
www.americanbankingnews.com - July 28 at 11:44 AM |
| HCA Holdings, Inc. to Post FY2017 Earnings of $7.14 Per Share, Oppenheimer Holdings Forecasts (HCA)
www.americanbankingnews.com - July 27 at 10:08 AM |
| FY2017 EPS Estimates for HCA Holdings, Inc. Reduced by Leerink Swann (NYSE:HCA)
www.americanbankingnews.com - July 27 at 10:08 AM |
| HCA Holdings, Inc. Forecasted to Post Q3 2017 Earnings of $1.69 Per Share (NYSE:HCA)
www.americanbankingnews.com - July 27 at 8:56 AM |
HCA Holdings (HCA) Chart for Tuesday, September, 19, 2017
